History
  • No items yet
midpage
Pasternack v. Laboratory Corp. of America Holdings
2015 U.S. App. LEXIS 19935
| 2d Cir. | 2015
Read the full case

Background

  • Dr. Fred Pasternack, an FAA-certified pilot and Senior Aviation Medical Examiner, was selected for a DOT/FAA random urine drug test on June 5, 2007; his first specimen was insufficient and he left the collection site to see a patient, returning ~3 hours later to provide a sufficient sample that tested negative.
  • The collector (LabCorp employee Theresa Montalvo) noted on the chain-of-custody form that Pasternack left and returned; a ChoicePoint Medical Review Officer (MRO) later designated the event a "refusal to test" and reported that to the employer and FAA.
  • The FAA investigated, relying on alleged false statements by the collector, and revoked Pasternack's airman certificates and terminated his AME designation; administrative appeals (NTSB, D.C. Cir.) ultimately reversed or remanded, and Pasternack’s certificates were later reinstated and the refusal finding expunged.
  • Pasternack sued LabCorp and ChoicePoint in federal court (diversity), asserting negligence, negligent misrepresentation, fraud, and injurious falsehood based on alleged failures to follow DOT/FAA testing regulations/guidelines and on false statements to investigators.
  • The district court dismissed the claims; on appeal the Second Circuit considered two unsettled questions of New York law and certified them to the New York Court of Appeals rather than resolve them.

Issues

Issue Plaintiff's Argument Defendant's Argument Held
Whether FAA/DOT drug-testing regulations/guidelines create a duty of care under New York negligence law Pasternack: the DOT/FAA regulations and collection guidelines impose concrete duties (e.g., shy-bladder protocol, warning that leaving may be a refusal) and thus create a state-law duty actionable in negligence LabCorp/ChoicePoint: federal regulations do not create a private right or state-law negligence duty; granting one would improperly convert regulatory violations into tort liability Certified to NY Court of Appeals as a determinative, unsettled question of New York law (decision reserved)
Whether a plaintiff may establish the reliance element of fraud by showing a third party relied on defendant's false statements causing plaintiff harm Pasternack: fraud can be proved when defendant's false statements to investigators (third parties) were relied on and caused plaintiff's injury Defendants: New York fraud law requires plaintiff's own reasonable reliance; third-party reliance is insufficient under Second Circuit precedent Certified to NY Court of Appeals as an unresolved, state-law question (decision reserved)

Key Cases Cited

  • Lombard v. Booz-Allen & Hamilton, Inc., 280 F.3d 209 (2d Cir. 2002) (elements of negligence under New York law)
  • Drake v. Laboratory Corp. of America Holdings, 458 F.3d 48 (2d Cir. 2006) (federal DOT/FAA drug-testing regulatory scheme and refusal-to-test issues; courts reluctant to recognize private right for regulatory violations)
  • Landon v. Kroll Laboratory Specialists, Inc., 22 N.Y.3d 1 (N.Y. 2013) (Court of Appeals allowed negligence claim against lab for mishandling sample leading to false positive)
  • Darby v. Compagnie Nationale Air France, 96 N.Y.2d 343 (N.Y. 2001) (court's role in determining existence and scope of duty)
  • Palka v. ServiceMaster Management Services Corp., 83 N.Y.2d 579 (N.Y. 1994) (duty-of-care is largely a legal, policy-laden question for courts)
  • Small v. Lorillard Tobacco Co., 94 N.Y.2d 43 (N.Y. 1999) (elements of fraud under New York law)
Read the full case

Case Details

Case Name: Pasternack v. Laboratory Corp. of America Holdings
Court Name: Court of Appeals for the Second Circuit
Date Published: Nov 17, 2015
Citation: 2015 U.S. App. LEXIS 19935
Docket Number: Docket No. 14-4101-cv
Court Abbreviation: 2d Cir.